Internal Medicine

Uzm. Dr. Abidin Gündoğdu

Doctor and researcher Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi İstanbul
Carcinoma, HepatocellularLiver Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Carcinoma, Hepatocellular 2 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Liver Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInternal Medicinesaglik.gov.trFrom source
  • Department name at the sourceİç Hastalıkları (Dahiliye)saglik.gov.trFrom source
  • InstitutionMarmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workCarcinoma, HepatocellularExtracted from 2 publications · Model version —From source
  • Publications13 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0002-6500-0648ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://marmaraeah.saglik.gov.tr/TR-1393244/doktorlarimiz.html#abidin-gundogdusaglik.gov.tr

Scientific work

Publications on Carcinoma, Hepatocellular

13 publications

  1. Glycemic Profiles of a Nation: Findings from Türkiye’s World Diabetes Day Screening Study

    Turkish Journal of Internal Medicine, 2026

    DOI 10.46310/tjim.1828705 Open-access full textSource: OpenAlex

  2. External validation of the PoPE score for predicting 30-day mortality in acute pulmonary embolism: a comparison with PESI and sPESI

    BMC Pulmonary Medicine, 2026

    DOI 10.1186/s12890-026-04917-5 Open-access full textSource: OpenAlex

  3. Sarcopenia and sarcopenic obesity in postmenopausal women: a cross-sectional study in Türkiye

    Climacteric, 2026

    DOI 10.1080/13697137.2025.2537982 PMID 40811081 1 citation (Europe PMC) Source: ORCID

  4. Machine learning-based identification of cardiovascular risk modifiers in patients with very high LDL cholesterol: A cross-sectional study

    Medicine, 2026

    DOI 10.1097/md.0000000000049866 PMID 42499084 Open-access full textSource: Europe PMC

  5. Extravasation of Intravenous Iron: Clinical Features and Therapeutic Considerations

    Case reports in hematology, 2026

    DOI 10.1155/crh/5531805 PMID 41624690 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  6. Factors Associated with Ferric Carboxymaltose‑Related Clinically Significant Hypophosphatemia: A Single-Center Retrospective Cohort Study

    Indian Journal of Hematology and Blood Transfusion, 2026

    DOI 10.1007/s12288-026-02439-y 1 citation (OpenAlex) Source: OpenAlex

  7. Machine Learning Based Identification Of Risk Modifiers In Patients With Very High Ldl Cholesterol

    2026

    DOI 10.13140/rg.2.2.20070.18242 Source: OpenAlex

  8. Fresh frozen plasma for angiotensin-converting enzyme inhibitor-induced angioedema

    Asian Journal of Transfusion Science, 2025

    DOI 10.4103/ajts.ajts_194_24 Open-access full textSource: OpenAlex

  9. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2305066 PMID 38263804 2 citations (Europe PMC) Source: OpenAlex

  10. Machine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission

    Turkish Journal of Internal Medicine, 2024

    DOI 10.46310/tjim.1502238 Open-access full textSource: OpenAlex

View all 13 publications